| 今开：5.8 | 昨收：5.8 |
| 最高：5.83 | 最低：5.2101 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.03410889E8 |
Solid Biosciences(SLDB)04-06 04:55
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-042322 Size: 7 KB 网页链接查看全文
Solid Biosciences(SLDB)04-27 04:25
$Solid Biosciences(SLDB)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-118095 Act: 34 Size: 1 MB 网页链接查看全文
Solid Biosciences(SLDB)06-06 04:15
$Solid Biosciences(SLDB)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001273087-24-000076 Act: 34 Size: 81 KB 网页链接查看全文
Solid Biosciences(SLDB)06-13 06:35
$Solid Biosciences(SLDB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-070940 Act: 34 Size: 85 KB 网页链接查看全文
Solid Biosciences(SLDB)06-12 04:15
$Solid Biosciences(SLDB)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-159100 Act: 33 Size: 195 KB 网页链接查看全文
Solid Biosciences(SLDB)06-14 04:15
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073013 Size: 5 KB 网页链接查看全文
Solid Biosciences(SLDB)05-20 18:05
$Solid Biosciences(SLDB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001565 Act: 33 Size: 1 KB 网页链接查看全文
Solid Biosciences(SLDB)06-12 08:45
$Solid Biosciences(SLDB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-24-159367 Act: 34 Size: 95 KB 网页链接查看全文
Solid Biosciences(SLDB)06-14 04:15
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-072992 Size: 5 KB 网页链接查看全文
Solid Biosciences(SLDB)04-27 04:25
$Solid Biosciences(SLDB)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-118115 Act: 34 Size: 2 MB 网页链接查看全文
美股滚雪球2023-01-12 12:19
$Solid Biosciences(SLDB)$ 和Phlox Therapeutics达成战略合作，开发针对遗传性心脏病的精准药物。这项研究合作将针对一种严重的遗传性扩张型心肌病(DCM)。
这项战略合作将整合Solid的载体生物学、制造能力和药物开发经验，以及Phlox在遗传心肌病和RNA治疗方面的专业知识。
两家公司表示，...查看全文
牛唐2022-10-03 15:50
医药板块速评（2022.09.30）
本期内容提示：
1、美股大盘跌跌不休，是否有抄底机会？$纳指100ETF-Invesco(QQQ)$
2、$Solid Biosciences(SLDB)、$Valneva SE(VALN)增发，是否有机会跟仓？
3、$贝壳(BEKE)$ 、$创新ETF-ARK(ARKK)$ 、$Twitter(TWTR)、$中概互联网指数ETF-KraneShares...查看全文
美股滚雪球2022-10-02 22:24
$Solid Biosciences(SLDB)$ 宣布收购基因治疗公司AavantiBio，旨在推进一系列神经肌肉和心脏项目，预计四季度完成合并。
交易完成后，AavantiBio现任首席执行官Bo Cumbo将担任Solid Biosciences的总裁兼首席执行官。
为支持此次收购，SLDB已与一些选定的机构投资者和合格投资者达成了一项...查看全文
$Solid Biosciences(SLDB)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-159100 Act: 33 Size: 195 KB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071765 Size: 4 KB 网页链接
$Solid Biosciences(SLDB)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001273087-24-000076 Act: 34 Size: 81 KB 网页链接
$Solid Biosciences(SLDB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001565 Act: 33 Size: 1 KB 网页链接
$Solid Biosciences(SLDB)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001193125-24-138930 Act: 33 Size: 687 KB 网页链接
$Solid Biosciences(SLDB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-060034 Act: 34 Size: 6 MB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-053774 Size: 10 KB 网页链接
$Solid Biosciences(SLDB)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-118079 Act: 34 Size: 2 MB 网页链接
$Solid Biosciences(SLDB)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-118095 Act: 34 Size: 1 MB 网页链接
$Solid Biosciences(SLDB)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-118115 Act: 34 Size: 2 MB 网页链接